Afamelanotide

Category: Genetic Disorders



Afamelanotide Overview

Afamelanotide, sold under the brand name Scenesse, is a synthetic peptide and analogue of α-melanocyte stimulating hormone used to prevent skin damage from the sun in people with erythropoietic protoporphyria in the European Union since January 2015, and the United States since October 2019. As a medication it is administered in subcutaneous implant form; the implant lasts for two months.[medical citation needed] The U.S. Food and Drug Administration (FDA) considers it ...

Read more Afamelanotide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Afamelanotide

Recent Afamelanotide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Afamelanotide
  • Implant: 16mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Afamelanotide or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA